U.S. Markets closed
  • S&P 500

    3,768.25
    -27.29 (-0.72%)
     
  • Dow 30

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • Russell 2000

    2,123.20
    -32.15 (-1.49%)
     
  • Crude Oil

    52.04
    -1.53 (-2.86%)
     
  • Gold

    1,827.70
    -23.70 (-1.28%)
     
  • Silver

    24.83
    -0.97 (-3.77%)
     
  • EUR/USD

    1.2085
    -0.0079 (-0.6526%)
     
  • 10-Yr Bond

    1.0970
    -0.0320 (-2.83%)
     
  • Vix

    24.34
    +1.09 (+4.69%)
     
  • GBP/USD

    1.3583
    -0.0057 (-0.4143%)
     
  • USD/JPY

    103.8710
    +0.0290 (+0.0279%)
     
  • BTC-USD

    37,433.68
    +415.39 (+1.12%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • FTSE 100

    6,735.71
    -66.25 (-0.97%)
     
  • Nikkei 225

    28,519.18
    -179.12 (-0.62%)
     

Top Ranked Value Stocks to Buy for December 28th

Zacks Equity Research
·2 min read

Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 28th:

Enova International, Inc. (ENVA): This technology and analytics company has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 63.6% over the last 60 days.

Enova International, Inc. Price and Consensus

Enova International, Inc. Price and Consensus
Enova International, Inc. Price and Consensus

Enova International, Inc. price-consensus-chart | Enova International, Inc. Quote

Enova has a price-to-earnings ratio (P/E) of 4.32 compared with 13.10 for the industry. The company possesses a Value Score of A.

Enova International, Inc. PE Ratio (TTM)

Enova International, Inc. PE Ratio (TTM)
Enova International, Inc. PE Ratio (TTM)

Enova International, Inc. pe-ratio-ttm | Enova International, Inc. Quote

A-Mark Precious Metals, Inc. (AMRK): This precious metals trading company has a Zacks Rank #2, and seen the Zacks Consensus Estimate for its current year earnings rising 72.6% over the last 60 days.

AMark Precious Metals, Inc. Price and Consensus

AMark Precious Metals, Inc. Price and Consensus
AMark Precious Metals, Inc. Price and Consensus

AMark Precious Metals, Inc. price-consensus-chart | AMark Precious Metals, Inc. Quote

A-Mark has a price-to-earnings ratio (P/E) of 4.63 compared with 13.30 for the industry. The company possesses a Value Score of B.

AMark Precious Metals, Inc. PE Ratio (TTM)

AMark Precious Metals, Inc. PE Ratio (TTM)
AMark Precious Metals, Inc. PE Ratio (TTM)

AMark Precious Metals, Inc. pe-ratio-ttm | AMark Precious Metals, Inc. Quote

Innoviva, Inc. (INVA): This company that is engaged in the development and commercialization of pharmaceuticals has Zacks Rank #1, and seen the Zacks Consensus Estimate for its current year earnings rising 24.3% over the last 60 days.

Innoviva, Inc. Price and Consensus

Innoviva, Inc. Price and Consensus
Innoviva, Inc. Price and Consensus

Innoviva, Inc. price-consensus-chart | Innoviva, Inc. Quote

Innoviva has a price-to-earnings ratio (P/E) of 5.61 compared with 14.60 for the industry. The company possesses a Value Score of A.

Innoviva, Inc. PE Ratio (TTM)

Innoviva, Inc. PE Ratio (TTM)
Innoviva, Inc. PE Ratio (TTM)

Innoviva, Inc. pe-ratio-ttm | Innoviva, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Value score and how it is calculated here.

Find more top income stocks with some of our great premium screens.

Just Released: Zacks’ 7 Best Stocks for Today

Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.4% per year.

These 7 were selected because of their superior potential for immediate breakout.

See these time-sensitive tickers now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Innoviva, Inc. (INVA) : Free Stock Analysis Report
 
AMark Precious Metals, Inc. (AMRK) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research